ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

Combination of Imatinib Mesylate and AKT Inhibitor Provides Synergistic Effects in Preclinical Study of Gastrointestinal Stromal Tumor.

Phillip Zook et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.